Telix Pharmaceuticals (TLX)
Commercializes prostate-cancer imaging agents while developing radiopharmaceutical diagnostics and treatments.
$11.24
vs last close−0.71 (−5.94%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Dec '23Feb '24May '24Aug '24Feb '25Aug '25Feb '26Aug '26
Reported$0.04$0.04—$0.06$0.11−$0.01−$0.01$0.11
Estimate—$0.05—$0.09$0.09$0.13$0.03$0.04
Surprise—−24.5%—−33.3%+22.5%−105.1%−135.4%+140.3%
RevenueReportedEstimate
Dec '23Feb '24May '24Aug '24Feb '25Aug '25Feb '26Aug '26
Reported$191.8M$184.8M$116.8M$246.5M$267.2M$390.4M$413.4M$477.0M
Estimate$112.6M$182.0M$112.6M$237.8M$135.1M$390.5M$418.5M$479.6M
Surprise+70.3%+1.5%+3.8%+3.6%+97.9%0.0%−1.2%−0.5%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2030 | $0.27 | — | — |
| Jun 2030 | $0.43 | — | — |
| Mar 2030 | $0.41 | — | — |
| Dec 2029 | $0.33 | — | — |
| Sep 2029 | $0.22 | — | — |
| Jun 2029 | −$0.03 | — | — |
| Mar 2029 | $0.07 | — | — |
| Dec 2028 | $0.06 | — | — |
| Sep 2028 | $0.05 | — | — |
| Jun 2028 | $0.13 | — | — |
| Dec 2027 | $0.07 | — | — |
| Jun 2027 | $0.05 | — | — |
| Feb 2027 | −$0.02 | — | — |
| Aug 2026 | $0.04 | $0.11 | +140.3% |
| Feb 2026 | $0.03 | −$0.01 | −135.4% |
| Aug 2025 | $0.13 | −$0.01 | −105.1% |
| Feb 2025 | $0.09 | $0.11 | +22.5% |
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Dec 2023 | |||
| Aug 2023 | |||
| Jun 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Feb 2022 | |||
| Dec 2021 | |||
| Jun 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Jun 2017 | |||
| Jan 2017 | |||
| Jun 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Dec 2014 | |||
| Sep 2014 | |||
| Jun 2014 | |||
| Mar 2014 | |||
| Dec 2013 | |||
| Sep 2013 | |||
| Jun 2013 | |||
| Mar 2013 | |||
| Dec 2012 | |||
| Sep 2012 | |||
| Jun 2012 | |||
| Mar 2012 | |||
| Dec 2011 | |||
| Sep 2011 | |||
| Jun 2011 | |||
| Sep 2000 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2030 | $0.27 | — | — | $9.13B | — | — | — |
| Jun 2030 | $0.43 | — | — | $1.28B | — | — | — |
| Mar 2030 | $0.41 | — | — | $1.07B | — | — | — |
| Dec 2029 | $0.33 | — | — | $1.16B | — | — | — |
| Sep 2029 | $0.22 | — | — | $855.1M | — | — | — |
| Jun 2029 | −$0.03 | — | — | $714.0M | — | — | — |
| Mar 2029 | $0.07 | — | — | $614.5M | — | — | — |
| Dec 2028 | $0.06 | — | — | $692.3M | — | — | — |
| Sep 2028 | $0.05 | — | — | $607.8M | — | — | — |
| Jun 2028 | $0.13 | — | — | $195.0M | — | — | — |
| Dec 2027 | $0.07 | — | — | $162.5M | — | — | — |
| Jun 2027 | $0.05 | — | — | $212.1M | — | — | — |
| Feb 19, 2027 | −$0.02 | — | — | $494.6M | — | — | — |
| Aug 19, 2026 | $0.04 | $0.11 | +140.3% | $479.6M | $477.0M | −0.5% | +2.0% |
| Feb 19, 2026 | $0.03 | −$0.01 | −135.4% | $418.5M | $413.4M | −1.2% | +14.6% |
| Aug 20, 2025 | $0.13 | −$0.01 | −105.1% | $390.5M | $390.4M | 0.0% | +10.2% |
| Feb 20, 2025 | $0.09 | $0.11 | +22.5% | $135.1M | $267.2M | +97.9% | +1.3% |
| Aug 22, 2024 | |||||||
| May 17, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Aug 23, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Aug 17, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Feb 23, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Jan 31, 2017 | |||||||
| Jun 30, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Dec 31, 2014 | |||||||
| Sep 30, 2014 | |||||||
| Jun 30, 2014 | |||||||
| Mar 31, 2014 | |||||||
| Dec 31, 2013 | |||||||
| Sep 30, 2013 | |||||||
| Jun 30, 2013 | |||||||
| Mar 31, 2013 | |||||||
| Dec 31, 2012 | |||||||
| Sep 30, 2012 | |||||||
| Jun 30, 2012 | |||||||
| Mar 31, 2012 | |||||||
| Dec 31, 2011 | |||||||
| Sep 30, 2011 | |||||||
| Jun 30, 2011 | |||||||
| Sep 30, 2000 |